
Cracking the Code: Understanding Congenital Myasthenic Syndrome 15
Explore Congenital Myasthenic Syndrome 15, its genetic causes, early diagnosis benefits, personalized treatments, and genetic testing's role in family planning.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore Congenital Myasthenic Syndrome 15, its genetic causes, early diagnosis benefits, personalized treatments, and genetic testing's role in family planning.

Explore congenital myasthenic syndrome 7, RAPSN gene mutations, and genetic testing's role in diagnosis, personalized treatment, and family planning insights.

Explore how genetic testing revolutionizes the diagnosis and management of CSABIPFDD Syndrome, offering insights into symptoms, treatment, and family planning.

Gain insights into DEE25, a rare neurological condition. Explore genetic testing's role in diagnosis, personalized treatment, and informed family planning.

Explore how genetic testing aids in diagnosing DEE26, informs personalized treatment plans, and offers vital familial insights for this rare neurological disorder.

Unlock the potential of genetic testing for DEE27: facilitate early diagnosis, personalized treatment, and informed family planning to transform patient outcomes.

Unravel how genetic testing aids in diagnosing and managing DEE28 by identifying mutations, leading to personalized treatment plans and informed family planning.

Explore how genetic testing aids in the early diagnosis and personalized treatment of Diamond-Blackfan Anemia 13, focusing on the RPS7 gene variant's impact.